Dr. Sugandha Dureja
@sugandhadureja
Nuclear Medicine Physician,trained in Theranostics/NM Therapy.Founder, CNETS India.Interests: Neuroendocrine tumors, patient doctor communication,health equity.
ID:83200083
17-10-2009 19:16:19
364 Tweets
359 Followers
338 Following
Even if a trial in a wealthy country benefited stomach cancer patients, extending their progression-free survival by weeks, it doesn't justify subjecting poor patients with limited healthcare access to these therapies, potentially impoverishing their families. #Pembrolizumab
Neuroendocrine tumors are easily missed
We need healthcare providers this #NETCancerDay to raise awareness of the signs and symptoms of neuroendocrine tumors Take a closer look at Neuroendocrine Cancer and its symptoms.
#LetsTalkAboutNETs CNETSIndia
Turned 40 today! Very grateful for everything I have been blessed with! ๐
#turning40 #Gratitude #ageisjustanumber
An honour and pleasure to attend the annual conference of Association of Nuclear Medicine Physicians of India, 2023. Discussed challenges in stand-alone theranostics.
Enjoyed the fantastic scientific program, hospitality & networking.
#anmpicon2023 #theranostics
Elyse Gellerman from NETRF, Sugandha Dureja from CNETS India, Mia Tepper from Healing NET Foundation, Jaydira Del Rivero from NANETS, and Lisa Yen from LACNETS at the INCA Summit
LACNETS Jaydira Del Rivero, MD NET Research Foundation Healing NET
#LetsTalkAboutNETs
#StrongerTogether
In #SCAN , top recommendations by NET patients and HCPs globally were to have more HCPs knowledgeable in NETs and better NET specialist/center access.
โ
Find insights in INCA article in JNE: rb.gy/5abhc
#LetsTalkAboutNETs #OncTwitter #EndoTwitter
Finally found some time for a weekend read! Halfway through, and looking forward to finish this beautiful, insightful book by Shelja Sen